FDA Greenlights Apple Watch Hypertension Feature Amid Health Industry Buzz

Recent health developments include the FDA's approval for Apple Watch hypertension features, Belgian contraceptive storage information, CDC's autism research contract, Kenvue CEO's talks with Robert F. Kennedy Jr., Trump officials' COVID vaccine claims, UnitedHealth's White House meeting efforts, and AstraZeneca's British investment pause.


Devdiscourse News Desk | Updated: 14-09-2025 18:34 IST | Created: 14-09-2025 18:34 IST
FDA Greenlights Apple Watch Hypertension Feature Amid Health Industry Buzz
This image is AI-generated and does not depict any real-life event or location. It is a fictional representation created for illustrative purposes only.

The U.S. Food and Drug Administration has approved a new hypertension detection feature in Apple Watches, allowing the tech giant to enhance its health-related offerings.

In Belgium, $10 million worth of U.S.-funded contraceptives are still in storage, despite previous destruction reports, sparking questions about international aid distribution.

The Centers for Disease Control and Prevention plans to contract Rensselaer Polytechnic Institute to investigate potential links between vaccines and autism, challenging ongoing debate on the topic.

Give Feedback